Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 49, Issue 3 (Mar 2011)

Issues

Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

Argonde C. van Harten
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Maartje I. Kester
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Pieter-Jelle Visser
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Psychiatry and Neuropsychology/Alzheimer Centre Limburg, School for Mental Health and Neurosciences, Maastricht University Medical Centre, Maastricht, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Marinus A. Blankenstein / Yolande A.L. Pijnenburg
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Wiesje M. van der Flier
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Epidemiology/Biostatistics, VU University Medical Centre, Amsterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Philip Scheltens
  • Alzheimer Centre, VU University Medical Centre, Amsterdam, The Netherlands
  • Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-02-23 | DOI: https://doi.org/10.1515/CCLM.2011.086

Abstract

Background: To evaluate the value of total tau (tau) and phosphorylated tau (p-tau) in cerebrospinal fluid (CSF) in the differential diagnosis of dementia, more specifically: dementia with Lewy Bodies (DLB), frontotemporal lobar degeneration (FTLD), vascular dementia (VaD), and Creutzfeldt-Jacob disease (CJD).

Methods: A systematic literature search was performed to identify studies on tau and p-tau in DLB, FTLD, VaD and CJD. Tau concentrations were compared to healthy controls and to subjects with Alzheimer's disease (AD) using random effect meta-analysis. Outcome measures were Cohen's delta, sensitivity and specificity.

Results: Compared to controls, tau concentrations are moderately elevated in DLB, FTLD and VaD, while p-tau concentrations are only slightly elevated in DLB and not elevated in FTLD and VaD. Compared to AD, lower tau concentrations differentiated DLB with a sensitivity of 73% and a specificity of 90%, FTLD with sensitivity and specificity of 74%, and VaD with a sensitivity of 73% and a specificity of 86%. Relative to AD, lower p-tau values differentiated FTLD with a sensitivity of 79% and specificity of 83%, and VaD with a sensitivity of 88% and a specificity of 78%. CJD is characterized by extremely elevated tau concentrations with a sensitivity of 91% and a specificity of 98% vs. AD.

Conclusions: CSF tau concentrations in DLB, FTLD and VaD are intermediate between controls and AD patients. Overlap with both controls and AD patients results in insufficient diagnostic accuracy, and the development of more specific biomarkers for these disorders is needed. CJD is characterized by extremely increased tau values, resulting in a sensitivity and specificity that exceeds 90%.

Keywords: Alzheimer's disease; Creutzfeldt-Jacob disease; dementia; dementia with Lewy bodies; frontotemporal lobe degeneration; meta-analysis; phosphorylated tau; tau (proteins); vascular dementia

About the article

Corresponding author: Argonde C. van Harten, Alzheimer Centre, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands


Received: 2010-12-06

Accepted: 2011-01-16

Published Online: 2011-02-23

Published in Print: 2011-03-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2011.086.

Export Citation

©2011 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Matteo Gastaldi, Elisabetta Zardini, Rosaria Leante, Maddalena Ruggieri, Gianna Costa, Eleonora Cocco, Giovanna De Luca, Ivana Cataldo, Tiziana Biagioli, Clara Ballerini, Massimiliano Castellazzi, Enrico Fainardi, Paola Pettini, Mauro Zaffaroni, Debora Giunti, Elisabetta Capello, Gaetano Bernardi, Emilio Ciusani, Claudia Giannotta, Eduardo Nobile-Orazio, Elena Bazzigaluppi, Gabriella Passerini, Roberta Bedin, Patrizia Sola, Rinaldo Brivio, Guido Cavaletti, Arianna Sala, Antonio Bertolotto, Gaetano Desina, Maurizio A. Leone, Sara Mariotto, Sergio Ferrari, Andreina Paternoster, Davide Giavarina, Francesco Lolli, and Diego Franciotta
Neurological Sciences, 2017, Volume 38, Number S2, Page 217
[3]
Yong Shen, Haibo Wang, Qiying Sun, Hailan Yao, Andrew P. Keegan, Mike Mullan, Jeffrey Wilson, Simone Lista, Thomas Leyhe, Christoph Laske, Dan Rujescu, Allan Levey, Anders Wallin, Kaj Blennow, Rena Li, and Harald Hampel
Biological Psychiatry, 2017
[4]
Niklas Mattsson, Anders Lönneborg, Marina Boccardi, Kaj Blennow, and Oskar Hansson
Neurobiology of Aging, 2017, Volume 52, Page 196
[5]
Joseph E. Gaugler, Robert L. Kane, Joseph A. Johnston, and Khaled Sarsour
American Journal of Alzheimer's Disease & Other Dementiasr, 2013, Volume 28, Number 4, Page 337
[6]
Bo Liu, Yulan Tang, Yuefei Shen, Luan Cen, and Min Han
American Journal of Alzheimer's Disease & Other Dementiasr, 2014, Volume 29, Number 2, Page 116
[7]
Yu Zhang, I-Wei Wu, Duygu Tosun, Eric Foster, Norbert Schuff, and Karl Herholz
PLOS ONE, 2016, Volume 11, Number 10, Page e0165540
[8]
David Andrés González and Jason R. Soble
The Clinical Neuropsychologist, 2017, Volume 31, Number 3, Page 676
[9]
Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, Ines Baldeiras, Maria Bjerke, Kaj Blennow, Sebastiaan Engelborghs, Giovanni B. Frisoni, Tomasz Gabryelewicz, Samantha Galluzzi, Ron Handels, Milica G. Kramberger, Agnieszka Kulczyńska, Jose Luis Molinuevo, Barbara Mroczko, Agneta Nordberg, Catarina Resende Oliveira, Markus Otto, Juha O. Rinne, Uroš Rot, Esen Saka, Hilkka Soininen, Hanne Struyfs, Silvia Suardi, Pieter Jelle Visser, Bengt Winblad, Henrik Zetterberg, and Gunhild Waldemar
Alzheimer's & Dementia, 2017, Volume 13, Number 3, Page 274
[10]
Amado Rivero-Santana, Daniel Ferreira, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio Sarría, and Pedro Serrano-Aguilar
Journal of Alzheimer's Disease, 2016, Volume 55, Number 2, Page 625
[11]
Franc Llorens, Matthias Schmitz, Daniela Varges, Niels Kruse, Nadine Gotzmann, Karin Gmitterová, Brit Mollenhauer, and Inga Zerr
Journal of Neurology, 2016, Volume 263, Number 11, Page 2271
[12]
Eric E. Brown, Yusuke Iwata, Jun Ku Chung, Philip Gerretsen, Ariel Graff-Guerrero, and Yumiko Motoi
Journal of Alzheimer's Disease, 2016, Volume 54, Number 2, Page 615
[13]
Gamze Balci Camsari, Melissa E. Murray, and Neill R. Graff-Radford
Neurologic Clinics, 2016, Volume 34, Number 3, Page 699
[14]
Franc Llorens, Matthias Schmitz, Isidro Ferrer, and Inga Zerr
Progress in Neurobiology, 2016, Volume 138-140, Page 36
[15]
Bruno Dubois, Harald Hampel, Howard H. Feldman, Philip Scheltens, Paul Aisen, Sandrine Andrieu, Hovagim Bakardjian, Habib Benali, Lars Bertram, Kaj Blennow, Karl Broich, Enrica Cavedo, Sebastian Crutch, Jean-François Dartigues, Charles Duyckaerts, Stéphane Epelbaum, Giovanni B. Frisoni, Serge Gauthier, Remy Genthon, Alida A. Gouw, Marie-Odile Habert, David M. Holtzman, Miia Kivipelto, Simone Lista, José-Luis Molinuevo, Sid E. O'Bryant, Gil D. Rabinovici, Christopher Rowe, Stephen Salloway, Lon S. Schneider, Reisa Sperling, Marc Teichmann, Maria C. Carrillo, Jeffrey Cummings, and Cliff R. Jack
Alzheimer's & Dementia, 2016, Volume 12, Number 3, Page 292
[16]
Sofie Sølvsten Sørensen, Ann-Britt Nygaard, and Thomas Christensen
Translational Neurodegeneration, 2016, Volume 5, Number 1
[17]
Omar Abuyaman and Ebba Nexo
Scandinavian Journal of Clinical and Laboratory Investigation, 2015, Volume 75, Number 6, Page 514
[18]
Aki Mishima, Takashi Nihashi, Yoshio Ando, Hisashi Kawai, Takashi Kato, Kengo Ito, and Teruhiko Terasawa
Journal of Alzheimer's Disease, 2015, Volume 50, Number 1, Page 161
[19]
Aaron Ritter and Jeffrey Cummings
Frontiers in Neurology, 2015, Volume 6
[20]
Franc Llorens, Niels Kruse, Matthias Schmitz, Mohsin Shafiq, José Eriton Gomes da Cunha, Nadine Gotzman, Saima Zafar, Katrin Thune, João Ricardo Mendes de Oliveira, Brit Mollenhauer, and Inga Zerr
Journal of Neurology, 2015, Volume 262, Number 10, Page 2305
[21]
Sara Galozzi, Katrin Marcus, and Katalin Barkovits
Expert Review of Proteomics, 2015, Volume 12, Number 4, Page 343
[22]
Tapan K. Khan and Daniel L. Alkon
Journal of Alzheimer's Disease, 2015, Volume 46, Number 4, Page 817
[23]
Tobias Skillbäck, Bahman Y. Farahmand, Christoffer Rosén, Niklas Mattsson, Katarina Nägga, Lena Kilander, Dorota Religa, Anders Wimo, Bengt Winblad, Jonathan M Schott, Kaj Blennow, Maria Eriksdotter, and Henrik Zetterberg
Brain, 2015, Volume 138, Number 9, Page 2716
[24]
Yi-pei Li, Guo-jun Yang, Li Jin, Hong-mei Yang, Jie Chen, Gao-shang Chai, and Li Wang
Brain Research, 2015, Volume 1618, Page 159
[25]
Mee-Ohk Kim and Michael D. Geschwind
Current Opinion in Neurology, 2015, Volume 28, Number 3, Page 302
[26]
Rachna Agarwal, Neelam Chhillar, Vijay Nath Mishra, and Chandra Bhushan Tripathi
Advances in Alzheimer's Disease, 2012, Volume 01, Number 03, Page 30
[27]
Patrick Oeckl, Petra Steinacker, Emily Feneberg, and Markus Otto
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2015, Volume 1854, Number 7, Page 757
[28]
Daniel Ferreira, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio Sarría, and Pedro Serrano-Aguilar
Frontiers in Aging Neuroscience, 2014, Volume 6
[29]
Ingrid Arevalo-Rodriguez, Omar Segura, Ivan Solà, Xavier Bonfill, Erick Sanchez, and Pablo Alonso-Coello
BMC Neurology, 2014, Volume 14, Number 1
[30]
Wei Tang, Qiong Huang, Yan Wang, Zheng-Yu Wang, and Yu-You Yao
Journal of the Neurological Sciences, 2014, Volume 345, Number 1-2, Page 26
[31]
P. Spitzer, Z. Kohl, P. Golitz, R. Coras, I. Blumcke, W. Bruck, A. Dorfler, and C. Maihofner
Case Reports, 2014, Volume 2014, Number jun02 1, Page bcr2012008510
[32]
Jeongmin Lee, Jae Wook Hyeon, Su Yeon Kim, Kyu-Jam Hwang, Young Ran Ju, and Chongsuk Ryou
Journal of Medical Virology, 2015, Volume 87, Number 1, Page 175
[33]
Wei Tang, Qiong Huang, Yu-You Yao, Yan Wang, Yi-Le Wu, and Zheng-Yu Wang
Journal of Neural Transmission, 2014, Volume 121, Number 12, Page 1541
[34]
Flora H. Duits, Charlotte E. Teunissen, Femke H. Bouwman, Pieter-Jelle Visser, Niklas Mattsson, Henrik Zetterberg, Kaj Blennow, Oskar Hansson, Lennart Minthon, Niels Andreasen, Jan Marcusson, Anders Wallin, Marcel Olde Rikkert, Magda Tsolaki, Lucilla Parnetti, Sanna-Kaisa Herukka, Harald Hampel, Mony J. De Leon, Johannes Schröder, Dag Aarsland, Marinus A. Blankenstein, Philip Scheltens, and Wiesje M. van der Flier
Alzheimer's & Dementia, 2014, Volume 10, Number 6, Page 713
[35]
Daniel Ferreira, Lilisbeth Perestelo-Pérez, Eric Westman, Lars-Olof Wahlund, Antonio Sarría, and Pedro Serrano-Aguilar
Frontiers in Aging Neuroscience, 2014, Volume 6
[36]
Joanna L. Richens, Kevin Morgan, and Paul O'Shea
Neurobiology of Aging, 2014, Volume 35, Number 9, Page 2029
[37]
Pavlina Sobrova, Iva Blazkova, Jana Chomoucka, Jana Drbohlavova, Marketa Vaculovicova, Pavel Kopel, Jaromir Hubalek, Rene Kizek, and Vojtech Adam
Prion, 2013, Volume 7, Number 5, Page 349
[38]
Garth F. Hall and Sudad Saman
Communicative & Integrative Biology, 2012, Volume 5, Number 6, Page 623
[39]
Garth F. Hall and Brian A. Patuto
Prion, 2012, Volume 6, Number 3, Page 223
[40]
F. Pasquier
Revue Neurologique, 2013, Volume 169, Number 10, Page 799
[41]
Lynn M. Bekris, Franziska Lutz, Thomas J. Montine, Chang En Yu, Debby Tsuang, Elaine R. Peskind, and James B. Leverenz
Biomarkers, 2013, Volume 18, Number 5, Page 455
[42]
Kevin F. Bieniek, Melissa E. Murray, Nicola J. Rutherford, Monica Castanedes-Casey, Mariely DeJesus-Hernandez, Amanda M. Liesinger, Matthew C. Baker, Kevin B. Boylan, Rosa Rademakers, and Dennis W. Dickson
Acta Neuropathologica, 2013, Volume 125, Number 2, Page 289
[43]
Katharina Stoeck, Pascual Sanchez-Juan, Joanna Gawinecka, Alison Green, Anna Ladogana, Maurizio Pocchiari, Raquel Sanchez-Valle, Eva Mitrova, Theodor Sklaviadis, Jerzy Kulczycki, Dana Slivarichova, Albert Saiz, Miguel Calero, Richard Knight, Adriano Aguzzi, Jean-Louis Laplanche, Katell Peoc’h, Gabi Schelzke, Andre Karch, Cornelia M. van Duijn, and Inga Zerr
Brain, 2012, Volume 135, Number 10, Page 3051
[44]
Lynn M. Bekris, Steve Millard, Franziska Lutz, Gail Li, Doug R. Galasko, Martin R. Farlow, Joseph F. Quinn, Jeffrey A. Kaye, James B. Leverenz, Debby W. Tsuang, Chang-En Yu, and Elaine R. Peskind
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2012, Volume 159B, Number 7, Page 874
[45]
S. Sorbi, J. Hort, T. Erkinjuntti, T. Fladby, G. Gainotti, H. Gurvit, B. Nacmias, F. Pasquier, B. O. Popescu, I. Rektorova, D. Religa, R. Rusina, M. Rossor, R. Schmidt, E. Stefanova, J. D. Warren, and P. Scheltens
European Journal of Neurology, 2012, Volume 19, Number 9, Page 1159
[46]
Jon B. Toledo, Johannes Brettschneider, Murray Grossman, Steven E. Arnold, William T. Hu, Sharon X. Xie, Virginia M.-Y. Lee, Leslie M. Shaw, and John Q. Trojanowski
Acta Neuropathologica, 2012, Volume 124, Number 1, Page 23
[47]
Nathalie Le Bastard and Sebastiaan Engelborghs
Neurodegenerative Disease Management, 2012, Volume 2, Number 2, Page 211
[48]
Axel Regeniter, Jens Kuhle, Thomas Baumann, Marc Sollberger, Markus Herdener, Ursula Kunze, Michael C. Camuso, and Andreas U. Monsch
Methods, 2012, Volume 56, Number 4, Page 494
[49]
Julie A. Fields, Tanis J. Ferman, Bradley F. Boeve, and Glenn E. Smith
Nature Reviews Neurology, 2011, Volume 7, Number 12, Page 677
[50]
S. Bombois, S. Schraen, B. Sablonniere, L. Buée, and F. Pasquier
Pratique Neurologique - FMC, 2011, Volume 2, Number 4, Page 256
[51]
Martijn C. de Wilde, Patrick J.G.H. Kamphuis, John W.C. Sijben, and Phillip Scheltens
European Journal of Pharmacology, 2011, Volume 668, Page S59
[52]
Luis F. Gonzalez-Cuyar, Joshua A. Sonnen, Kathleen S. Montine, C. Dirk Keene, and Thomas J. Montine
Current Neurology and Neuroscience Reports, 2011, Volume 11, Number 5, Page 455

Comments (0)

Please log in or register to comment.
Log in